Daiwa Securities Group’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3K Hold
206
﹤0.01% 1199
2025
Q1
$3K Buy
+206
New +$3K ﹤0.01% 1168
2022
Q4
Sell
-4
Closed 1373
2022
Q3
$0 Hold
4
﹤0.01% 1383
2022
Q2
$0 Hold
4
﹤0.01% 1410
2022
Q1
$0 Hold
4
﹤0.01% 1403
2021
Q4
$0 Hold
4
﹤0.01% 1433
2021
Q3
$1K Hold
4
﹤0.01% 1278
2021
Q2
$1K Hold
4
﹤0.01% 1208
2021
Q1
$1K Hold
4
﹤0.01% 1222
2020
Q4
$1K Sell
4
-6
-60% -$1.5K ﹤0.01% 1201
2020
Q3
$2K Buy
10
+4
+67% +$800 ﹤0.01% 1134
2020
Q2
$1K Hold
6
﹤0.01% 1178
2020
Q1
$1K Hold
6
﹤0.01% 1187
2019
Q4
$1K Hold
6
﹤0.01% 1176
2019
Q3
$1K Hold
6
﹤0.01% 1146
2019
Q2
$1K Hold
6
﹤0.01% 1167
2019
Q1
$1K Buy
+6
New +$1K ﹤0.01% 1154